Skip to main content
Clinical Trials/JPRN-UMIN000033589
JPRN-UMIN000033589
Completed
未知

The feasibility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: prospective randomized control study - Nutrition support for PC patients with NACRT

Osaka International Cancer Institute0 sites60 target enrollmentAugust 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Resectable and borderline resectable pancreatic cancer pateints
Sponsor
Osaka International Cancer Institute
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2018
End Date
March 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients were excluded from the study when they don't met the following eligibility criteria: (1\) an Eastern Cooperative Oncology Group performance status of 0\-1; (2\) adequate hepatic, renal, and bone\-marrow reserves (AST and ALT levels below twice the normal levels; total serum bilirubin \<3\.0 mg/dl; creatinine level \<1\.3 mg/dl; leukocyte count\>2,000/mm3; hemoglobin \>10 g/dl; platelet count \>100,000/mm3\); (3\) capable of oral intake, and (4\) written informed consent provided before randomization.

Outcomes

Primary Outcomes

Not specified

Similar Trials